A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored. Devon Tyso, a Product Design and Technology student, has ...

OXFORD, UK / ACCESSWIRE / January 24, 2024 / New clinical studies confirm high efficacy and total safety of Thermobalancing therapy and wearable Dr Allen's Device in providing pain relief in patients ...

Testing and treatment of prostate cancer is triggering both a huge public debate in the United States and an outpouring of interesting new technology using plastics devices. At the heart of both ...

The "Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market" report has been added to Research and Markets' offering. This analysis includes a discussion of products, competitors, ...

SAN FRANCISCO, July 09, 2025--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and ...

Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minnesota, announced that it has secured market ...

Thermobalancing therapy with Dr Allen's Device treats chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) effectively and safely, helping to prevent the development of benign prostatic ...

Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...

The iTind device complements Olympus' ablative benign prostatic hyperplasia portfolio by offering a stent-like treatment that preserves prostate tissue and sexual function. (Getty Images) () After ...

A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored. Subscribe to our newsletter for the latest sci-tech news ...